FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111796677> ?p ?o ?g. }

• W3111796677 abstract "Abstract Leukemogenesis is facilitated by deregulated survival signals and escape from immunosurveillance. For immunological control both adequate stimulation of effector cells as well as apoptosis sensitivity of target cells are required. The CD40 receptor, a member of the TNF/NGF receptor family, plays a pivotal role on normal B cells in both aspects as it upregulates the costimulatory molecules enhancing their antigen presenting capacity and the CD95 TNF receptor sensitizing cells to apoptotic stimuli. Due to its physiological immunomodulatory functions, we prospectively studied the prognostic impact of CD40 expression on primary precursor B (BCP)-ALL blasts of pediatric patients (pts) (n=121). Blasts exhibited an immunephenotype of c-ALL (n=81), preB-ALL (n=32) or proB-ALL (n=8). All pts (>1 and <17y) were treated according to the CoALL06-97 study protocol. The criteria for prognostic classification into high risk (HR; n=57) and low risk (LR; n=64) pts at initial diagnosis include immunephenotype, leukocyte count (WBC), age, genetic translocations and the in vitro resistance to chemotherapeutic agents (PVA score). In flow cytometry analysis blasts exhibited a broad range of CD40 expression with a mean of 80%±27% (±SD) positive blasts. In terms of the above mentioned prognostic discrimination criteria, we found significantly lower percentage of CD40 positive blasts in HR pts (median; range: 84%;3–100%) compared to the LR group (98%;3–100%) (p=0.007). With regard to prognostic relevance, pts with very high percentage (above the mean of 80%) CD40 positive blasts exhibited significantly better relapse free survival (RFS; 0.86±0.06 vs 0.65±0.09; p=0.009) in Kaplan Meier analysis and multivariate Cox regression analysis revealed that high CD40 expression was independently associated with superior RFS in our pediatric ALL pt cohort (p=0.006) in contrast to the risk factors age (p=0.72), WBC (p=0.33) and PVA score (p=0.60). In a subset of patients (n=34) we examined whether the level of CD40 expression corresponds to the capacity of blasts to upregulate costimulatory molecules and the CD95 death receptor upon CD40-ligation. CD40-crosslinking in samples with a very high percentage of CD40 positive blasts (>80%) and with intermediate/low expression of CD40 (<80%) did not result in significantly different upregulation of CD80 (37%;3–97% vs 41%;4–68%) and CD86 (83%;5–100% vs 72%;12–96%) in the two sample-sets (p=0.66 and p=0.86). In contrast, expression of CD95 in CD40-stimulated blasts showed a significant correlation with CD40 baseline expression (p=0.009) with a higher percentage of CD95 positive blasts following CD40-activation in samples containing >80% CD40 positive blasts compared to samples with intermediate/low CD40 expression (74%;17–95% vs 38%;9–94%; p=0.065). Thus, high percentage of CD40 positive blasts is an independent prognostic marker that identifies a group of pediatric BCP-ALL pts with favorable outcome. While the capacity to upregulate costimulatory molecules following CD40-activation might contribute to the observed improvement in survival, enhanced upregulation of the CD95 receptor seems to be the leading mechanism mediating sensitization towards apoptotic stimuli." @default.
• W3111796677 created "2020-12-21" @default.
• W3111796677 creator A5004533869 @default.
• W3111796677 creator A5016298566 @default.
• W3111796677 creator A5017322730 @default.
• W3111796677 creator A5022986622 @default.
• W3111796677 creator A5041468866 @default.
• W3111796677 creator A5050030248 @default.
• W3111796677 creator A5050663577 @default.
• W3111796677 creator A5058130884 @default.
• W3111796677 creator A5061408567 @default.
• W3111796677 creator A5073356326 @default.
• W3111796677 date "2006-11-01" @default.
• W3111796677 modified "2023-09-28" @default.
• W3111796677 title "High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95." @default.
• W3111796677 cites W105534366 @default.
• W3111796677 cites W1572465651 @default.
• W3111796677 cites W1654343738 @default.
• W3111796677 cites W1783681636 @default.
• W3111796677 cites W1857920654 @default.
• W3111796677 cites W1970619712 @default.
• W3111796677 cites W1970768125 @default.
• W3111796677 cites W1979918788 @default.
• W3111796677 cites W1985610617 @default.
• W3111796677 cites W2014314146 @default.
• W3111796677 cites W2020441955 @default.
• W3111796677 cites W2025743629 @default.
• W3111796677 cites W2050097010 @default.
• W3111796677 cites W2052560076 @default.
• W3111796677 cites W2052964146 @default.
• W3111796677 cites W2058411331 @default.
• W3111796677 cites W2058431553 @default.
• W3111796677 cites W2095310460 @default.
• W3111796677 cites W2113011666 @default.
• W3111796677 cites W2137303107 @default.
• W3111796677 cites W2317499156 @default.
• W3111796677 cites W2345971816 @default.
• W3111796677 cites W350247456 @default.
• W3111796677 cites W4674812 @default.
• W3111796677 cites W68180527 @default.
• W3111796677 doi "https://doi.org/10.1182/blood.v108.11.2282.2282" @default.
• W3111796677 hasPublicationYear "2006" @default.
• W3111796677 type Work @default.
• W3111796677 sameAs 3111796677 @default.
• W3111796677 citedByCount "0" @default.
• W3111796677 crossrefType "journal-article" @default.
• W3111796677 hasAuthorship W3111796677A5004533869 @default.
• W3111796677 hasAuthorship W3111796677A5016298566 @default.
• W3111796677 hasAuthorship W3111796677A5017322730 @default.
• W3111796677 hasAuthorship W3111796677A5022986622 @default.
• W3111796677 hasAuthorship W3111796677A5041468866 @default.
• W3111796677 hasAuthorship W3111796677A5050030248 @default.
• W3111796677 hasAuthorship W3111796677A5050663577 @default.
• W3111796677 hasAuthorship W3111796677A5058130884 @default.
• W3111796677 hasAuthorship W3111796677A5061408567 @default.
• W3111796677 hasAuthorship W3111796677A5073356326 @default.
• W3111796677 hasConcept C121608353 @default.
• W3111796677 hasConcept C126322002 @default.
• W3111796677 hasConcept C143998085 @default.
• W3111796677 hasConcept C154317977 @default.
• W3111796677 hasConcept C170493617 @default.
• W3111796677 hasConcept C17991360 @default.
• W3111796677 hasConcept C202751555 @default.
• W3111796677 hasConcept C203014093 @default.
• W3111796677 hasConcept C2776885095 @default.
• W3111796677 hasConcept C39347974 @default.
• W3111796677 hasConcept C50382708 @default.
• W3111796677 hasConcept C553184892 @default.
• W3111796677 hasConcept C55493867 @default.
• W3111796677 hasConcept C71924100 @default.
• W3111796677 hasConcept C86803240 @default.
• W3111796677 hasConceptScore W3111796677C121608353 @default.
• W3111796677 hasConceptScore W3111796677C126322002 @default.
• W3111796677 hasConceptScore W3111796677C143998085 @default.
• W3111796677 hasConceptScore W3111796677C154317977 @default.
• W3111796677 hasConceptScore W3111796677C170493617 @default.
• W3111796677 hasConceptScore W3111796677C17991360 @default.
• W3111796677 hasConceptScore W3111796677C202751555 @default.
• W3111796677 hasConceptScore W3111796677C203014093 @default.
• W3111796677 hasConceptScore W3111796677C2776885095 @default.
• W3111796677 hasConceptScore W3111796677C39347974 @default.
• W3111796677 hasConceptScore W3111796677C50382708 @default.
• W3111796677 hasConceptScore W3111796677C553184892 @default.
• W3111796677 hasConceptScore W3111796677C55493867 @default.
• W3111796677 hasConceptScore W3111796677C71924100 @default.
• W3111796677 hasConceptScore W3111796677C86803240 @default.
• W3111796677 hasLocation W31117966771 @default.
• W3111796677 hasOpenAccess W3111796677 @default.
• W3111796677 hasPrimaryLocation W31117966771 @default.
• W3111796677 hasRelatedWork W1992710641 @default.
• W3111796677 hasRelatedWork W2012247149 @default.
• W3111796677 hasRelatedWork W2356108812 @default.
• W3111796677 hasRelatedWork W2524976195 @default.
• W3111796677 hasRelatedWork W2529376761 @default.
• W3111796677 hasRelatedWork W3082907133 @default.
• W3111796677 hasRelatedWork W3141582650 @default.
• W3111796677 hasRelatedWork W3198647362 @default.
• W3111796677 hasRelatedWork W396249626 @default.
• W3111796677 hasRelatedWork W2526598190 @default.
• W3111796677 isParatext "false" @default.

• next